Vice President / Senior Vice President
Janux Therapeutics
Vice President / Senior Vice President
Janux Therapeutics
Clinical-stage biotech developing tumor-activated immunotherapies
Salary Range: 350000 to 450000 (Currency: USD) (Pay period: per-year-salary)
Clinical-stage biotech developing tumor-activated immunotherapies
Janux Therapeutics develops cancer immunotherapies that activate the immune system inside tumors to attack cancer while sparing healthy tissue. Its products are tumor-activated and use a proprietary platform masking technology to reduce toxic side effects and improve efficacy compared with traditional T cell engagers. The company advances drug candidates through clinical trials, aiming for regulatory approval and eventual commercialization, with revenue expected from partnerships, licensing, and the sale of approved therapies. Its lead program JANX007 is being evaluated in a Phase 1 trial (ENGAGER PSMA 01) for metastatic prostate cancer to assess safety and preliminary effectiveness.
Explore more opportunities at Janux Therapeutics